lactic acid has been researched along with abt-737 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koyakutty, M; Menon, D; Menon, KN; Mony, U; Nair, MS; Nair, SV; Pavithran, K; Sidharthan, N | 1 |
| Hu, Z; Jin, R; Qiu, Y; Wang, L; Wu, X; Zhang, B | 1 |
2 other study(ies) available for lactic acid and abt-737
| Article | Year |
|---|---|
Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells.
Topics: Biphenyl Compounds; Cell Adhesion; Cell Proliferation; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fibronectins; Humans; Lactic Acid; Leukemia, Myeloid, Acute; Nanocomposites; Nanofibers; Nitrophenols; Piperazines; Polyesters; Polymers; Polyurethanes; Sulfonamides; Tissue Scaffolds | 2015 |
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Drug Liberation; Drug Synergism; Female; Humans; Interleukin-1 Receptor-Associated Kinases; Jurkat Cells; Lactic Acid; Mice; Nanoparticles; Nitrophenols; Piperazines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sulfonamides; Xenograft Model Antitumor Assays | 2017 |